Martina Hansens Hospital AS
- Address
- lock Available on a paid plan
Immune System Diseases
The research at Martina Hansens Hospital AS concentrates on immune‑mediated disorders, testing innovative therapies and monitoring strategies to achieve sustained disease control.
- Evaluation of proactive therapeutic drug monitoring in rheumatoid arthritis
- Secukinumab combined with glucocorticoid taper in giant cell arteritis
- Comparative effectiveness of biologic versus conventional treatment approaches
By integrating advanced drug‑level assessments, the site aims to improve outcomes for patients with rheumatoid arthritis and giant cell arteritis across Norway.
Musculoskeletal Diseases
Studies at the orthopedic department target joint and bone conditions, seeking therapies that reduce pain, limit disease progression, and potentially avoid surgery.
- Ultrasound‑guided injection therapy versus primary surgery for carpal tunnel syndrome
- Zoledronic acid as disease‑modifying agent in hip osteoarthritis
- Long‑term management strategies for osteoarthritis of the hip
The goal is to provide patients with safer, effective options for carpal tunnel syndrome and hip osteoarthritis, leveraging treatments such as zoledronic acid.
Nervous System Diseases
The site’s investigations include peripheral nerve disorders, focusing on minimally invasive interventions and functional recovery.
- Assessing outcomes of ultrasound‑guided injections for carpal tunnel syndrome
- Evaluating postoperative recovery protocols after nerve decompression
- Integrating imaging biomarkers to guide treatment of nerve compression
Through these efforts, Martina Hansens Hospital AS aims to enhance quality of life for individuals affected by carpal tunnel syndrome and related neuropathies.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Diakonhjemmet Sykehus AS1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Diakonhjemmet Sykehus AS3trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 112 other sites in Norway
Therapeutic Area Benchmark — Norway
Select a therapeutic area to compare against other sites in Norway.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Norway
Market Share
Country: Norway
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Martina Hansens Hospital AS
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Comparative Study of Triamcinolone Acetonide and Triamcinolone Hexacetonide Injection Strategies Versus Surgical Intervention in Carpal Tunnel Syndrome | Diakonhjemmet Sykehus AS | Phase III | Not Recruiting | Apr 2022 | — |
IMP list
lock Showing 1 of 6 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Triamcinolone Acetonide | 2 | Unknown | 2022-04-08 | 2023-11-03 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.